Wen et al. demonstrated that targeted inhibition of the TGF-β/Smad pathway effectively eliminated the EMT program and metastatic potential of ovarian CSCs.481 FZD7 activates the TGF-β1/Smad3 pathway to confer stemness to pancreatic cancer cells. Here, TGFB1 is linked to pancreatic neoplasm.